Janus Biotech introduces a paediatric-friendly, strawberry-flavoured tablet combining Bilastin 10 mg and Montelukast 4 mg to tackle both allergic rhinitis and mild-to-moderate asthma in children aged 6–12 years. Crafted in our WHO-GMP compliant facility, the formulation offers once-daily convenience, fast onset of relief, and non-sedating comfort. As one of the trusted Bilastin 10mg Kid Tablet Third Party Manufacturers, we adhere to stringent quality checks, batch-wise COA, and child-safe packaging.
Bilastin blocks peripheral H1 histamine receptors to stop sneezing, itching, and watery eyes, while Montelukast inhibits leukotriene-mediated airway inflammation, preventing bronchoconstriction. Together, they deliver dual protection—controlling allergic triggers during the day & safeguarding the airways at night.
• Relieves seasonal & perennial allergic rhinitis
• Preventing exercise-induced bronchospasm
• Controls mild persistent asthma symptoms
• Reduces night-time coughing and nasal congestion
• Improves overall respiratory comfort in paediatric patients
• Mild headache
• Occasional abdominal discomfort
• Drowsiness (rare)
• Dry mouth or throat irritation
• Usually transient and self-limiting when taken as directed
We are recognized both as a reliable Bilastin 10mg Kid Tablet Third Party Manufacturers and a dependable Montelukast 4mg Kid tablet third party supplier. Partners gain DCGI-approved formulations, low MOQs, and region-wise monopoly rights. Our marketing kit – visual aids, reminder cards, and sample packs – accelerates doctor engagement, while prompt logistics ensure zero stockouts. Distributors seeking expansion can also tap our PCD Pharma Franchise for Bilastine 10 Mg Kid tablets, benefitting from high margins, minimal risk, and complete promotional backing.
Join hands with Janus Biotech, the trusted Montelukast 4mg Kid tablet third party supplier in India. And unlock new development with our PCD Pharma Franchise for Bilastine 10 Mg Kid tablets today.